buyModerate
Kyle Cerminara bought $218k of FGC
CEO and Chairman at FG Nexus Inc.. 10,000 shares at an average of $21.77, traded Nov 26, 2024, filed Nov 29, 2024.
Conviction score
42Value
$218k
10,000 shares
Holdings after
78,131
+3% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +12Trade size$218k at market
- 0Relative to holdingsHoldings up 3.1%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying3 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-131791, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 26, 2024 | POpen-market purchase Common Stockindirect: FG Financial Holdings, LLC | +3,000 | $29.92 | $90k | 329,965 | Nov 29, 2024 |
| Nov 26, 2024 | POpen-market purchase 8.00% Cumulative Preferred Stock, Series A, $25.00 par valueindirect: FG Financial Holdings, LLC | +7,000 | $18.28 | $128k | 78,131 | Nov 29, 2024 |
Related signals
Other insiders at FG Nexus Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | FGCbuy FG Nexus Inc. | Michael C Mitchell director | $164k 10,000 shares | +326% | |
| 25Weak | FGCsell FG Nexus Inc. | Scott D Wollney director | $30k 1,000 shares | -23% | |
| 42Moderate | FGCbuy FG Nexus Inc. | Kyle Cerminara CEO and Chairman | $92k 4,979 shares | +8% | |
| 40Moderate | FGCbuy FG Nexus Inc. | Kyle Cerminara CEO and Chairman | $351k 15,021 shares | +5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.